MLKL is a prognostic biomarker for cervical squamous cell carcinoma and has recently been identified as a key RIPK3 downstream component of TNF-induced necroptosis (Ruan et al., 2015). This evidence concerns the gene MLKL and cervical squamous cell carcinoma.